Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P61236
UPID:
YPEL3_HUMAN
Alternative names:
-
Alternative UPACC:
P61236; Q65Z99; Q86VK6; Q9BSJ4; Q9CQB6
Background:
Protein yippee-like 3 plays a crucial role in the regulation of cell proliferation and apoptosis among myeloid precursor cells. Its unique function positions it as a key player in hematopoiesis, the process responsible for the production of blood cells.
Therapeutic significance:
Understanding the role of Protein yippee-like 3 could open doors to potential therapeutic strategies. Its involvement in fundamental cellular processes suggests that targeting this protein could lead to innovative treatments for hematological disorders.